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Abstract 
Candida albicans is an opportunistic fungal pathogen that can cause a potentially 
lethal systemic infection in immunocompromised patients. Increasing drug resistance of 
Candida species to anti-fungal treatments makes the study of this pathogen ever more 
important. Study of the C. albicans cell wall provides insight into its importance in 
pathogenesis, immune recognition, and anti-fungal action. It has been shown that β-
glucan, a masked component of the fungal cell wall and ligand for the immune receptor 
Dectin-1, becomes available for immune recognition in the mouse model of systemic 
candidiasis. To develop a mechanistic model to explain this unmasking, we investigated 
the interaction between the C. albicans cell wall and the innate immune system in vitro. 
Our research suggests that neutrophils can wrap around fungal filaments and release 
components of their lysosomes, including proteases, onto the cell wall. This interaction 
can result in damage to cell wall-associated proteins and the subsequent unmasking of β-
glucan. Our research also suggests that proteases can mediate this unmasking. We 
speculate these neutrophil-damaged fungal filaments may elicit a greater pro-
inflammatory response from innate immune cells through increased recognition by 
Dectin-1. Our research sheds light on the interactions between the fungal cell wall and 
the innate immune system, which could lead to more efficacious treatments for those 
suffering from systemic candidiasis.  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Introduction 
Candidiasis 
Candidiasis, an infection caused by Candida species, is clinically important and 
demands further study and attention. Candida bloodstream infections, also known as 
candidemia, have been shown to result in a two times greater risk of death, longer 
hospital stays, and higher hospital costs than blood stream infections not caused by 
Candida species. (Pfaller and Diekema, 2012; Shorr et al., 2009). Candidiasis is a leading 
health care –associated infection and is particularly formidable as it often occurs in 
immunocompromised hosts, including those with HIV or those who have recently 
undergone organ transplantation or chemotherapy. Other risk factors for developing 
candidiasis include the use of antibiotics, steroids, or indwelling catheters (Pfaller and 
Diekema, 2012).  
Candidiasis can manifest either as a disseminated bloodstream infection, 
candidemia, or a mucosal infection like oropharengyeal candidiasis, also known as 
thrush, and the common vulvovaginal infection (Moran et al., 2012). While the mucosal 
infections are not associated with mortality like the bloodstream infection, thrush often 
indicates an underlying disease like HIV or uncontrolled diabetes (Lynch, 1994; 
Revankar and Sobel, 2012), and the vulvovaginal infection is very common affecting 
about 75% of women of childbearing age (Hurley and de Louvois, 1979; Revankar and 
Sobel, 2012).  
There are four classes of antifungal drugs that deal with these infections; 
polyenes, pyrimidine analogs, azoles, and echinocandins, with the last two being the most 
recently discovered (Nett and Andes, 2012). Azoles like fluconazole disrupt the fungal 
membrane by inhibiting the production of a membrane component called ergosterol 
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(Como and Dismukes, 1994; Heimark et al., 2002; Nett and Andes, 2012). Azoles can be 
used for both systemic and mucosal infections and are considered a safe alternative to 
older antifungals (Como and Dismukes, 1994; Nett and Andes, 2012; Pappas et al., 
2009). Echinocandins inhibit the synthesis of β-1,3 glucan, an important component of 
the Candida cell wall, have few side effects, and currently low levels of resistance 
making them a favored treatment (Chandrasekar and Sobel, 2006; Dodds Ashley et al., 
2006; Nett and Andes, 2012; Vazquez and Sobel, 2006). However the recent rise in 
resistance to anti-fungals makes their study and the study of Candida species crucial 
(Pfaller et al., 2011).  
 
The Pathogen C. albicans 
Although there are many species of Candida, C. albicans predominates as it is the 
causative agent in about 64% of candidemia cases (Pfaller and Diekema, 2012; Pfaller et 
al., 2005). C. albicans is a polymorphic fungus, meaning it has three morphologies; the 
yeast form, filamentous form, and the pseudohypal form. C. albicans is also a commensal 
organism colonizing 30-60% of the population without causing symptoms (Clayton and 
Noble, 1966; Moran et al., 2012). As a commensal organism, C. albicans has naturally 
evolved along with the host’s immune system making it uniquely capable of evading 
recognition and destruction. The balance between the commensal organism and the host 
immune system is delicate, so that when the host is immunocompromised, C. albicans 
can proliferate unchecked and cause a serious infection (Pfaller and Diekema, 2012). One 
of the ways that C. albicans has been able to avoid recognition by the immune system is 
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through the layered nature of its cell wall, which will be explained in more detail later 
(Chaffin et al., 1998). 
 
The Human Defense- The Immune System 
The immune system is made up of two branches; the adaptive and the innate. 
Both of these branches play an important role in protection against pathogens. The 
adaptive branch can be found along the evolutionary web from jawed fishes to more 
complex organisms like mammals and consists of antibodies and lymphocytes. While 
adaptive immunity has precise specificity and memory for the smallest patterns on a 
pathogen, it also has a significant lag time for development. While adaptive immunity is 
developing, the innate branch of the immune system is in charge of protecting the host. 
Innate immunity can be found to different extents in all multicellular organisms. The 
components of the innate immune system are physical barriers, mucosal linings, and a 
variety of phagocytes, including neutrophils and macrophages. While this part of the 
immune system has no memory of the pathogens it comes in contact with, the response is 
immediate and can prevent an infection from taking hold before the adaptive immunity 
has time to respond (Kindt et al., 2007).  
One of the first responders of the innate immune system is the neutrophil. The 
neutrophil has the highest concentration in the blood stream of all of the phagocytes and 
has a variety of methods for the neutralization of pathogens. When a neutrophil 
recognizes a pathogen it engulfs the foreign organism and encloses it in a vesicle called a 
phagosome. This phagosome fuses with a lysosome containing destructive compounds. 
If, however, a neutrophil cannot engulf the pathogen, if for instance, the pathogen is a    
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C. albicans filament, the neutrophil performs “frustrated phagocytosis,” where the 
neutrophil wraps around the pathogen and releases the contents of the lysosome out onto 
the fungal cell surface (Henson, 1971). The compounds within the lysosome include 
reactive oxygen species (ROS) like hypochlorous acid (HClO), anti-microbial peptides, 
and proteases (Kindt et al., 2007). There is a variety of information about the importance 
of each of these compounds, and whether they act independently or synergistically, thus 
it is an area that invites further research (Christin et al., 1997; Diamond et al., 1978; 
Kindt et al., 2007; Reeves et al., 2002). In the context of a C. albicans infection, 
neutropenia, or a deficiency in the ability to produce neutrophils, is an important risk 
factor in the development of both systemic and mucosal candidiasis (Heimark et al., 
2002), highlighting the importance of neutrophils in the defense against C. albicans 
infections.  
To recognize pathogens like C. albicans the cells of the innate immune system 
use pattern recognition receptors (PRRs) to recognize pathogen-associated molecular 
patterns (PAMPs), which are general patterns on the pathogen that can induce an immune 
response through the innate immune cell. Recognition through these PRRs induces the 
production of pro-inflammatory cytokines like TNF-α, which then recruit additional 
innate immune cells to the site of infection producing an amplifying effect, so that the 
infection can be neutralized. That first step of recognition is key because without it the 
immune response and neutralization of the infection cannot occur (Kindt et al., 2007). 
An important PPR for the detection of C. albicans is Dectin-1. This receptor has 
been shown to help in resistance to fungal infections by recognizing β-glucan, an 
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important structure in the C. albicans cell wall (Brown and Gordon, 2001; Taylor et al., 
2007). 
 
C. albicans Cell Wall  
The cell wall of C. albicans helps the organism to evade the host’s immune 
system’s recognition. The cell wall is layered with a thin outer layer of mannoproteins 
linked to an underlying thick layer of β-glucan, effectively masking it from recognition 
by Dectin-1. Chemically, β-glucan is glucose linked together with β1,3- and β1,6 –
linkages and it is those linkages that Dectin-1 recognizes (Figure 1) (Brown and Gordon, 
2001; Chaffin et al., 1998). The importance of β-glucan lies in its specificity to fungi. 
While the innate immune system can recognize both the mannoprotein and β-glucan 
layers, β-glucan is a uniquely fungal characteristic, which makes it a more valuable 
PAMP for an organized attack (Brown et al., 2003; Brown et al., 2002). 
The study of β-glucan and the fungal cell wall is not only important as it is the site 
of recognition by innate immune cells, but also because β-glucan is proving to be an 
important target for therapeutics. Antifungals like capsofungin, an echinocandin, target β-
glucan as a site for its fungicidal effects (Dodds Ashley et al., 2006; Nett and Andes, 
2012). A study in 2005 also implicated β-glucan’s use in a potential vaccine against 
pathogenic fungus (Torosantucci et al., 2005). 
 
Previous Work 
It has been shown that the antifungal caspofungin exposed β-glucan from the 
masking effect of the mannoprotein layer (Wheeler et al., 2008) and that these cells with 
exposed β-glucan induced TNF-α production (Wheeler and Fink, 2006). These studies 
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were performed with C. albicans filaments as they demonstrated increased susceptibility 
to β-glucan exposure by caspofungin. A change in recognition patterns was also observed 
through this work. On days one through three of the infection, recognition of the C. 
albicans filaments was based mostly on mannan recognition. But by day five of the 
infection there was increasing levels of β-glucan exposure, indicating that the mechanism 
for recognition by immune cells could be altered to both mannan and β-glucan based 
recognition. The change from day three to day five seen in vivo was the spark that led to 
this research, and to develop a better understanding what is happening between day three 
and day five of the murine kidney infection is the purpose of this research (Wheeler et al., 
2008). 
 
Goals 
Based on the previous work that was done by Wheeler et al., 2008, further 
investigation into the interactions between the C. albicans cell wall and the innate 
immune system in vitro was warranted. We know that β-glucan is exposed in the murine 
kidney infection between days three and five, so what we are interested in is 
understanding how β-glucan becomes exposed and the interaction between the fungal cell 
wall and the innate immune system, specifically regarding neutrophils, which is currently 
unknown (Figure 2). Through this research we will better understand how the fungal cell 
wall reacts to attacks from the innate immune system and how we can aid the immune 
system to fight infections and develop a better understanding of this antifungal target. In 
order to achieve these goals we examined the following:  
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a. The C. albicans Cell Wall and Whole Neutrophils 
The first goal of this research was to investigate the interactions between the 
C. albicans cell wall and whole neutrophils. Primary murine neutrophils were 
used to model human neutrophils. Fluorescent biotinylation and 
immunofluorescence staining, using anti-β-glucan, were used to observe the 
changes in the C. albicans cell wall. 
 
b. Using Neutrophil Elastase as an Indicator of Neutrophil Attachment 
Upon observing the potential effect of neutrophils on the fungal cell wall, we 
wanted to confirm the attachment of neutrophils to the fungal filaments. After 
incubation with primary neutrophils, the fungal filaments were stained with 
both anti-β-D-glucan and anti-neutrophil elastase followed by fluorescent 
secondary antibodies and colocalization between these two markers was 
observed.  
 
c. A Protease’s Effect on the Fungal Cell Wall 
Our second goal was to understand the potential of proteases to mediate the 
damage seen at the C. albicans cell wall. We used proteinase K, a commonly 
used serine protease, to model how proteases may be able to affect the 
changes seen at the fungal cell wall due to whole neutrophils. Here 
transmission electron microscopy and immnuofluorescence techniques were 
used to probe changes in the fungal cell wall and identify β-glucan exposure 
and changes in the fungal cell wall. 
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d. Recognition of β-glucan by Macrophages and the Subsequent Induction 
of Proinflammatory Cytokines 
Our last goal of this research was to understand the recognition and signaling 
effects of β-glucan exposure. KAH3, a strain of C. albicans with known β-
glucan exposure and C. albicans damaged by neutrophils were used in these 
experiments. TNF-α production by cultured macrophages was used as an 
indication of recognition. Sandwich enzyme-linked immunosorbent assays 
(ELISAs) were performed to measure levels of TNF-α in the supernatant. 
 
Materials and Methods 
C. albicans Strains and Growth 
Two strains of C. albicans were used through these experiments. One wild-type 
strain, SC5314-GFP, was used for experimental procedures, and a mutant strain, KAH3, 
with exposed β-glucan, was used for controls. For growth of C. albicans the first culture 
was made by inoculating one colony from an overnight YPD plate (2 % Peptone, 1% 
yeast extract, 2% glucose, 2% agar) into 5 mL of liquid YPD media (2% Peptone, 1% 
yeast extract, 2%  glucose). Liquid cultures were incubated overnight in a rollerdrum at 
37°C. The next day the overnight cultures were diluted to 2.5x106 cells/mL into 25 or 50 
mL Roswell Park Memorial Institute (RPMI-1640) media with 25 mM HEPES, L-
glutamine (Lonza Biowhittaker) and 1% penicillin-streptomycin, aliquoted in 5 mL 
aliquots and incubated overnight in a rollerdrum at 30°C. The following day the culture 
was pooled and centrifuged at 3000xg for 3 minutes. The supernatant was removed and 
the cells were set at 3x108 cells/mL and stored on ice until needed. 
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Neutrophil Extraction and Purification 
Two C57BL/6J mice (The Jackson Lab) were sacrificed and the bone marrow 
from the femurs and tibias was removed and disassociated into 5% Fetal Bovine Serum 
(FBS) in 1x phosphate buffered saline (PBS) (Lonza) and filtered through a 70 µm filter. 
The bone marrow was centrifuged at 1000xg for 3 minutes and TAC buffer (0.017 M 
Tris-HCL, 0.114 M NH4Cl) was used to lyse red blood cells (3 ml for 1 minutes). Cells 
were then diluted in 2% FBS and counted using a 1:5 dilution into Turk’s Solution 
(0.01% crystal violet, 3% acetic acid). The cells were then resuspended at 10-100 M 
cells/mL and were labeled using anti-Ly6 Biotin at 1 µL Ab/100 µL neutrophils, for 15 
minutes on ice and anti-Biotin MicroBeads (Pierce Biotechnology) at 10 µL/10 M cells, 
for 15-30 minutes on ice, washing with 2% FBS between each incubation. Then the 
labeled cells were purified using the Miltenyibiotec AutoMACS purification system. The 
purified neutrophils were centrifuged again at 1000xg for 3 minutes and resuspended in 2 
mL of RPMI with 5% FBS, and were counted in Trypan Blue at a 1:10 dilution 
(BioWhittaker). 
 
Biotinylation 
The C. albicans cells that were resuspended at 3x108 cells/mL, at a volume of 100 
µL cells/sample were washed in 1xPBS pH 8.0. The cells were then labeled with biotin-
xx SSE (Molecular Probes) at 5 µL biotin/100 µL C. albicans for 15 minutes at room 
temperature and fluorescently labeled streptavidin at a 1:50 dilution (Appendix I). The 
cells were washed with 1xPBS pH7.2 (Lonza) in between incubations. Finally the 
concentration of the biotinylated cells was measured using OD600 and the final 
concentration was adjusted to 3x108 cells/mL. 
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C. albicans Treatment with Neutrophils and Neutrophil Lysis 
The purified neutrophils, at 7x106 cells, were incubated with C. albicans, 100 µL 
at 3x108 cells/mL, at 37°C for 2.5 hours spinning constantly. After the incubation the 
neutrophils were lysed using 100 µL of 0.02% TritonX-100 (Sigma) for 1 minute. The 
cells were then washed with 1xPBS pH 7.2 three times. If neutrophils were still present, 
they were treated with 0.04% TritonX-100 for 1 minute and washed again in 1xPBS pH 
7.2 three times. 
 
Immunofluorescence Staining 
First the C. albicans cells were blocked in 2% bovine serum albumin (BSA) in 
1xPBS for 30 minutes at room temperature. The cells were then washed with 2% BSA 
and labeled with primary antibody: anti-β-glucan mouse IgG (Biosupplies Australia) at 
1:800, and anti-neutrophil elastase goat IgG (Santa Cruz Biotechnology) at 1:50 at 4°C 
overnight. The next day the cells were washed with 2% BSA in 1xPBS and the cells were 
labeled with secondary antibodies. For a full list of antibodies used see Appendix II. 
 
Fluorescence Microscopy 
An Axio Observer.Z1 fluorescence microscope from Carl Zeiss, Inc. was used to 
image fluorescently labeled C. albicans filaments. Both a Plan-Apochromat 20x objective 
with a numerical aperature of 0.8 and an EC Plan-Neofluor 40x objective with a 
numerical aperature of 0.75 were used. The images taken were overlays of up to three 
fluorescent images and differential interference contrast (DIC) images. The three 
fluorescent filter settings with excitations/emissions were HE GFP (470 nm/525 nm), 
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Rhodamine (546 nm/575 nm), and Cy5 (640 nm/690 nm). Images were taken using an 
AxioCam and were visualized using AxioVisionLE software.  
 
Quantification using CellProfiler 
Fluorescent images of multiple fields of each sample were used to gather 
quantitative data. The files generated using AxioVisionLE software were transferred to a 
TIF format and loaded into the CellProfiler program (www.cellprofiler.org). Images were 
observed in the GFP channel (testing viability of the C. albicans cells) to allow for blind 
selection in respect to anti-β-glucan and streptavidin labeling. Cells were only selected if 
they were isolated, meaning they were not layered with other cells, and the ends of 
filaments were mostly avoided although some were used (Figure 3). Using the 
CellProfiler program individual segments were outlined, quantifying approximately the 
same number for both samples treated with and without neutrophils for each of three 
individual experiments This method only collected data on the outside of the outlined 
cells, and represented changes on a cell segment-wide basis. Data were collected from the 
rhodamine (anti-β-glucan) and far-red (streptavidin, cell wall protein) channels and 
imported into Microsoft Excel. 
 
Quantification using AxioVisionLE Software 
Using the rhodamine (anti β-glucan) channel, areas with and without β-glucan 
exposure were chosen if they were not overlayed on other cells and were not on the ends 
of cells. Then a box, of constant area and perimeter, was used to select the edge of the 
cell wall and measure the average fluorescence within that box in the rhodamine and far-
red (streptavidin, cell wall protein) channels. The areas were designated either “exposed” 
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if there was a strong, visible pattern of β-glucan exposure or “control” if there were no 
signs of fluorescence in the rhodamine channel. Areas with overly bright fluorescence in 
the rhodamine channel were avoided in case they were due to free secondary antibody 
trapped on or in between cells (Figure 4). The data tables were transferred to Microsoft 
Excel where the levels of streptavidin and β-glucan were compared between those “with” 
β-glucan exposure and “without” β-glucan exposure. 
 
Treatment with Proteinase K 
C. albicans cells were washed three times and resuspended in RPMI-1640 at 
3x107 cells (100 µL of 3x108 cells/mL). The following was added to the C. albicans 
filaments, and for those cells not receiving proteinase K treatment, the volume was made 
up with 1xPBS: 30% fresh RPMI-1640, 0.6 M sorbitol, 3.0 mM CaCl2 738 µg/mL of 
proteinase K. For exact volumes used, see Appendix III. 
 
Electron Microscopy 
After proteinase K treatment, C. albicans cells were washed with RPMI-1640 and 
fixed in 2% formaldehyde, 2% gluteraldehyde, 1 mM CaCl2, 1 mM sorbitol, and 40 mM 
potassium phosphate buffer for 1 hour at room temperature. Then the fungal cells were 
washed once each with 40 mM potassium phosphate buffer with 0.75 M, 0.5 M, 0.25 M 
sorbitol, and without sorbitol. The C. albicans cells were then stored at 4°C until they 
were sent to the Integrated Imaging Center at the Johns Hopkins University. There they 
were embedded in agarose at approximately 1:1 and cut to approximately 1 mm3. The 
blocks were then post-fixed in 1% OsO4 and 1% potassium ferrocyanide in 0.1 M 
cacodylate/ 5 mM CaCl2 for 1 hour at room temperature. They were washed in ddH2O 
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and treated with 0.5% sodium meta-periodate for 15 minutes at room temperature. The 
blocks were then washed once in 50 mM potassium phosphate pH 7.4 and resuspended in 
50 mM ammonium phosphate pH 7.4 for 15 minutes. The blocks were then washed again 
in ddH2O and then stained in Kellenberger’s uranyl acetate for 2 hours to overnight. The 
blocks were dehydrated in a 50-100% graded series of ethanol at 4°C and left overnight 
in 100% ethanol at room temperature. Next they were washed three times for 15 minutes 
each in 100% ethanol, and washed twice with propylene oxide and placed in a 50:50 
mixture of PO and Spurr resin. These blocks were then rotated for 8-12 hours and placed 
under a vacuum overnight. The resin was then changed twice over 6-8 hours and left 
overnight in a third change. The next day the blocks were vacuum dried over the course 
of a day. The blocks were then placed in beam capsules with Spurr resin and cooked for 
24-48 hours at 60-80°C. The sections were then cut and post-stained with lead citrate for 
2-5 minutes and imaged using an FEI Technai 12 transmission electron microscope with 
an Olympus SIS Megaview III CCD digital camera.  
 
Macrophages 
RAW264.7 macrophages were grown in RPMI-1640 with 5% FBS and split the 
day prior to the challenge with C. albicans cells and set at about 5x105 cells/well in a 24-
well plate and incubated overnight at 37°C with 5% CO2.  
 
UV Inactivation 
An overnight C. albicans culture (either SC5314-GFP or KAH3) was diluted to 
2.5x107 cells/mL and washed in 1xPBS pH 7.2 (Lonza). 1 mL/well of each C. albicans 
strain in 1xPBS pH 7.2 was inactivated using four treatments at 100,000 µJ/cm2 in a CL-
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1000 UV-crosslinker (UVP, Upland California, United States) with a 90° rotation 
between each treatment. The contents of the wells were then removed and washed three 
times with 1xPBS pH 7.2 and the concentration was measured by OD600. These cells 
were set at a concentration of 1x106 cells/well before they were added to the 
macrophages.  
 
Macrophage and C. albicans Interaction 
C. albicans and RAW264.7 macrophages were incubated together at 5x105 
macrophages/well and about 3x107 C. albicans cells unless otherwise specified. These 
were then incubated at 37°C with 5% CO2. At 2 hours and 4 hours the plate was removed 
from the incubator and 0.4 mL of supernatant was removed, spun down at 15000 rpm for 
1 minutes. Then 300 µL supernatant was removed and spun down for 5 minutes. Finally 
200 µL of the supernatant was collected and stored at 4°C. 
 
TNF-α Detection 
A DuoSet ELISA for mouse TNF-α from R&D Systems was used to detect TNF-
α produced by macrophages in the collected supernatant. The assay was performed 
according to instructions included in the kit. The top standard of TNF-α was 4000 pg/mL.  
 
Results 
Time-lapse observation of neutrophil- mediated, localized damage of cell wall –
associated protein 
In the murine kidney infection, we see a dramatic shift to β-glucan-based 
recognition with the exposure of this cell wall motif (Wheeler et al., 2008). The ability of 
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neutrophils to damage the cell wall of C. albicans has been previously described (Christin 
et al., 1997; Diamond et al., 1978; Lehrer and Cline, 1969). We hypothesized that 
neutrophils may cause localized damage to the outer, masking mannoprotein layer and 
thereby expose the underlying β-glucan.  To test the relationship between neutrophil 
attachment and cell wall damage we first examined these dynamics in real time using 
time-lapse microscopy. We incubated filamentous WT-GFP C. albicans with purified 
murine primary neutrophils at 37°C for 2.5 hours. Prior to incubation the C. albicans 
cells were biotinylated using biotin-xx SSE and labeled with streptavidin-AlexaFluor 
647. After incubation with purified neutrophils, the C. albicans filaments were stained 
with anti-β-D-glucan antibody followed by a fluorescently conjugated secondary 
antibody.  
Time-lapse images were taken during the incubation between neutrophils and 
biotinylated C. albicans filaments to observe their interaction in real time. Two separate 
events can be seen in this time-lapse (Figure 5). In the event outlined in Box 1, a 
neutrophil attaches to a C. albicans filament at 6 minutes after the neutrophils were added 
to the suspension. Within two minutes a decrease in streptavidin labeling of cell wall 
proteins is seen, which continues to decrease until 44 minutes when the time lapse ends. 
Another site of neutrophil attachment is highlighted in Box 2. This neutrophil migrates to 
a C. albicans filament at lands on the filament at 14 minutes. The neutrophil then 
stretches out and wraps around the filament by 18 minutes. Although the neutrophil 
remains on the fungal filament and starts to rebound to its original shape at 32 minutes, 
no decrease in streptavidin is seen throughout the whole 44 minute-long time lapse 
(Figure 5). This observation of the second neutrophil both eliminates occlusion as a 
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possible reason for the decrease in labeling, and indicates not all neutrophil-fungal 
interactions result in cell wall damage. These observations support previous work 
demonstrating that neutrophils can cause damage to cell wall proteins (Christin et al., 
1997; Diamond et al., 1978; Lehrer and Cline, 1969), seen here in a localized manner. 
 
Neutrophil-mediated damage to fungal cell wall-associated proteins correlates 
with exposure of β-glucan  
We have seen that neutrophils can directly damage cell wall-associated proteins. 
To determine how this damage relates to the exposure of β-glucan, we quantified both 
cell wall protein labeling and β-glucan exposure on fungal filaments exposed to 
neutrophils. We fluorescently-labeled cell wall proteins of C. albicans filaments using 
biotin-xx SSE and fluorescently-labeled streptavidin and incubated them with purified 
murine neutrophils for 2.5hr at 37°C. After incubation the neutrophils were lysed and the 
C. albicans filaments were stained with anti-β-D-glucan antibody followed by a 
fluorescently conjugated secondary antibody. Fluorescence microscopy images were 
quantified using the CellProfiler quantification software, which allowed us to quantify the 
average fluorescence levels over a whole cell segment. Individual cell segments were 
outlined by hand, using the cytoplasmic GFP within live cells as a guide. Then the 
average level of fluorescence in each channel was calculated for the cell segments. To 
eliminate bias, segment choice and outlining was performed blind to both streptavidin 
and anti-β-glucan labeling. Only those segments that were clearly separated from other 
parts Using this quantification technique, we saw that C. albicans filaments that were 
exposed to neutrophils had an increase in the ratio of β-glucan staining to fluorescent 
streptavidin labeling, on a cell-by-cell basis (Figure 6A).  
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However, this could imply an increase in β-glucan exposure, a decrease in 
streptavidin-labeled cell wall proteins or both. To better characterize these neutrophil-
mediated changes in the cell wall, we identified areas with β-glucan exposure and areas 
without β-glucan exposure and quantified the levels of β-glucan staining and fluorescent 
streptavidin labeling at those defined areas using the AxioVisionLE quantification 
technique. Through this technique we identified and measured localized areas of anti-β-
glucan labeling and measured the streptavidin labeling at those specific sites of β-glucan 
exposure. The result was the identification of an inverse relationship between β-glucan 
staining and fluorescent streptavidin labeling (Figure 6B). Where there was localized β-
glucan exposure, there was also a decrease in fluorescent cell wall protein labeling. From 
this data we know that neutrophils can somehow damage the masking layer of cell wall 
proteins, thereby exposing β-glucan. This indicates that it could be the action of 
neutrophils that cause β-glucan exposure in the murine kidney infection.  
 
Neutrophil elastase deposition on fungal filaments indicates location of neutrophil 
attachment.  
After observing cell wall-associated protein damage and β-glucan exposure, we 
wanted to confirm that the β-glucan exposure was due to neutrophil attachment. Liu et 
al., 2006 used an anti-neutrophil elastase antibody to identify the presence of innate 
immune cells in granulomas associated with schistosomiasis. We adopted this technique 
along with our already established protocol using biotinylated C. albicans and purified 
neutrophils followed by immunofluorescence staining. We saw colocalization between 
anti-neutrophil elastase antibody and anti-β-glucan antibody in those C. albicans 
filaments treated with whole neutrophils (Figure 7A). Overall we observed that wherever 
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there was β-glucan exposure there was also neutrophil elastase present, although there 
were many instances where there was neutrophil elastase staining without β-glucan 
exposure, supporting our finding that not all neutrophil-fungal interactions result in cell 
wall damage. In addition to treating C. albicans cells with whole neutrophils, we also 
added lysed neutrophils to C. albicans filaments after both had been incubated at 37°C 
for 2.5 hours. The fungal filaments with neutrophil lysate did not have any localized β-
glucan exposure with neutrophil elastase colocalization, although they did have a limited 
amount of neutrophil elastase labeling (Figure 7B). Filaments alone had only miniscule 
amounts of anti-neutrophil elastase labeling, most likely due to non-specific anti-
neutrophil elastase antibody binding (Figure 7C). These results strongly suggest that β-
glucan exposure is due to the direct action of neutrophils that locally damages the cell 
wall. 
 
Proteinase K alters the structure of the outer cell wall protein layer and exposes 
β-glucan 
We have shown that neutrophils can damage cell wall proteins and expose β-
glucan and that neutrophil elastase is present at these sites. This suggested that 
neutrophils may use proteases to damage the outer cell wall protein layer, thereby 
unmasking β-glucan. While it has been shown that protease inhibitors do not decrease the 
neutrophil’s ability to damage cell wall proteins, and that proteases independently cannot 
induce cell wall damage (Christin et al., 1997), proteases have proven to be important in 
elastase deficient mice that had a decreased ability to resist infection by C. albicans 
(Reeves et al., 2002). To better understand the potential role for proteases to alter the cell 
wall and expose β-glucan, we treated WT-GFP C. albicans filaments with or without 
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0.74mg/mL of proteinase K overnight at 37°C, then used both transmission electron 
microscopy (TEM) and immunofluoresence staining to observe the changes in the fungal 
cell wall. TEM images exhibited an obvious altering of the outer mannoprotein layer 
(Figure 8). Upon treatment with proteinase K, the mannoprotein layer appears altered and 
stains more faintly with lead citrate. This data suggests that proteases can damage the 
masking mannoprotein layer and this is consistent with previous studies suggesting that 
proteases play an important role in resistance to fungal infections (Reeves et al., 2002).  
Artifacts due to the fixation process of the samples for TEM necessitated imaging 
of live cells using immunofluorescence staining. We saw that treatment with proteinase K 
also induced the exposure of β-glucan (Figure 9). We quantified these images using the 
CellProfiler quantification technique to observe β-glucan exposure on a cell-by-cell basis. 
Fungal filaments treated with proteinase K had significantly more β-glucan exposure than 
the filaments that did not receive treatment. This immunofluorescence data, along with 
the TEM observations, suggests that proteases can damage the outer mannoprotein layer 
and expose β-glucan.  
 
C. albicans and neutrophil lysate induce higher levels of TNF-α production by 
macrophages than C. albicans alone 
Once we had established the ability of neutrophils to expose β-glucan by 
damaging cell wall proteins, we wanted to investigate the importance of this β-glucan 
exposure in the recognition and response of other innate immune cells to damaged fungi. 
β-glucan exposed using caspofungin, has been shown to hyperelicit TNF-α from bone 
marrow derived macrophages (Wheeler and Fink, 2006). To determine if neutrophil-
mediated exposure of β-glucan was physiologically relevant, we challenged macrophages 
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with C. albicans and measured TNF-α elicitation. We measured TNF-α elicitation from 
macrophages by enzyme-linked immunosorbent assay (ELISA) of RAW264.7 
macrophage supernatant. First we performed control experiments using KAH3, a strain of 
C. albicans with known β-glucan exposure and a wild-type strain as a control. KAH3 and 
SC5314-GFP yeast form cells were UV inactivated and then incubated with RAW264.7 
macrophages for 2 hours at 37°C with 5% CO2 at an effector to target ratio of 1:2. After 
incubation the supernatant was removed and a sandwich ELISA was performed to detect 
TNF-α. The result was there was no significant difference in the induction of TNF-α 
between the two strains or the negative controls (Figure 10A). This could suggest either 
that the KAH3 strain of C. albicans and WT-GFP strains cannot elicit TNF-α production 
from RAW264.7 macrophages or that our experimental design was inappropriate for 
measuring TNF-α production.  
To determine if neutrophil-damaged C. albicans filaments could elicit TNF-α, we 
performed ELISAs on the supernatant of RAW264.7 macrophages incubated with fungal 
filaments damaged by neutrophils as previously described. After incubation with the 
fungal filaments, the neutrophils were lysed and β-glucan exposure was confirmed by a 
parallel sample set stained by immunofluorescence. C. albicans filaments undamaged by 
whole neutrophils were added to lysed neutrophils after incubation and undamaged C. 
albicans filaments alone were used as a control. C. albicans filaments treated with whole 
neutrophils or filaments that had lysed neutrophils added to them elicited significantly 
more TNF-α production than the C. albicans alone (Figure 10B). In addition, C. albicans 
filaments alone elicited significantly more TNF-α than the negative control (Figure 10B). 
These results suggest that C. albicans with lysed neutrophils increases the induction of 
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TNF-α from macrophages, which is supported by previous work (Fadok et al., 2001). 
These results indicate that it could be more the contents of the neutrophils that are 
exciting the macrophages to produce TNF-α. While C. albicans filaments can elicit TNF-
α production, the effect due to neutrophil lysate may be masking any elicitation due to β-
glucan exposure.  
 
Discussion 
As an opportunistic pathogen, C. albicans poses a great risk to 
immunocompromised patients whose immune systems have already been weakened due 
to HIV, organ transplantation, or chemotherapy (Pfaller et al., 2011). Increasing 
resistance to anti-fungal treatments makes the study of natural defense mechanisms 
against fungi like C. albicans imperative (Pfaller et al., 2011). In the mouse model, β-
glucan, a uniquely fungal component of the cell wall, becomes unmasked late in the 
systemic infection (Wheeler et al., 2008). The importance of β-glucan lies in its roles as a 
pathogen-associated molecular pattern (PAMP) for recognition by innate immune cells, a 
target for anti-fungal treatment, and a potential component for a vaccine against 
candidiasis (Nett and Andes, 2012; Taylor et al., 2007; Torosantucci et al., 2005). 
Through my research we have developed a mechanistic model to explain the dynamic 
unmasking of fungal β-glucan as seen in the murine kidney infection (Wheeler et al., 
2008). For this model we have established that neutrophils can wrap around fungal 
filaments, release proteases, and possibly use those proteases to damage cell wall-
associated proteins and subsequently cause β-glucan exposure. We have also begun to 
investigate the role of neutrophil-damaged C. albicans in recognition by macrophages.    
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Neutrophils can wrap around fungal filaments and mediate cell wall damage and 
β-glucan exposure 
We hypothesized that the β-glucan exposure seen in the murine kidney infection 
could be caused by neutrophils. Our research has shown that neutrophils can wrap around 
fungal filaments, damage outer cell wall-associated proteins, and expose β-glucan 
(Figures 5 and 6). We have also confirmed the presence of neutrophils at these sites of β-
glucan exposure using the deposition of neutrophil elastase as an indicator of neutrophil 
attachment (Figure 7).  In addition, we have observed both in time-lapse images and 
through the use of anti-neutrophil elastase that not all neutrophil-fungal interactions result 
in cell wall-associated protein damage and β-glucan exposure (Figures 5 and 7).  Our 
results here support previous findings that neutrophils can damage the fungal cell wall 
(Christin et al., 1997; Diamond et al., 1978; Lehrer and Cline, 1969), and support our 
hypothesis that neutrophils could mediate the β-glucan exposure seen in vivo.  
 Methods for probing the three-dimensional structure of the C. albicans cell wall 
presents both advantages and disadvantages. For the detection of β-glucan, we decided to 
use an anti-β-D-glucan antibody because its epitope has been well characterized (Meikle 
et al., 1991), it is versatile and commercially available, and it is large enough to represent 
physiological relevance. If we were to use the carbohydrate recognition domain of 
Dectin-1 (Dectin-CRD), we would not have had the options available to us through the 
use of secondary antibodies. In my research we used many different fluorophores and the 
added flexibility of secondary antibodies allowed us to change the fluorophore as 
necessary. Also if we had decided not to use an antibody to detect β-glucan exposure, we 
would have had to manufacture the Dectin-1 probe ourselves, instead of purchasing a 
primary antibody. However the use of anti-β-D-glucan may not be a completely accurate 
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representation of recognition of this exposed PAMP, because it is an antibody, not the 
Dectin-1 receptor found naturally on innate immune cells. It has been confirmed, 
however, that anti-β-D-glucan labeling mirrors labeling with Dectin-CRD, especially 
when combined with a secondary antibody, to account for size (Wheeler et al., 2008). In 
addition, monomeric Dectin-1 is only 28kDa (Brown et al., 2007) and the typical 
antibody is 150kDa (Janeway Jr. et al., 2001) implying that if an antibody can locate and 
bind to β-glucan, so should Dectin-1. As we wanted to observe damage that is 
physiologically relevant, using a larger probe would allow us to see only areas with large 
amounts β-glucan exposure. It has been suggested that Dectin-1 may form clusters in vivo 
(Goodridge et al., 2011), further emphasizing the importance in using a probe that 
identifies only large areas of β-glucan exposure, perhaps sufficient enough to 
accommodate multiple Dectin-1 receptors. That being said, to truly understand the 
accessibility of β-glucan exposure to innate immune cells, studies would have to be done 
with neutrophils or macrophages to determine the physiological relevance of changed 
epitope exposure. 
 Another method we used to fluorescently probe the fungal cell wall is through 
biotinylation. Biotinylation offers the opportunity to observe and measure cell wall 
proteins, but also introduces some concerns. In my research, we see a decrease in 
streptavidin labeling corresponding to an increase in β-glucan exposure, although the use 
of concanavalin A (ConA) to probe the masking layer of the cell wall has not 
demonstrated a decrease in strains of C. albicans with exposed β-glucan (Wheeler and 
Fink, 2006). This could be due to a couple of reasons. First, the ligands for ConA and 
biotin are different. ConA is a mannose-specific lectin and it binds to the sugars of the 
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mannoprotein layer while succinimidyl-derivitized biotin forms covalent bonds with free 
amines of the protein component (Molecular Probes). In the mannoprotein layer of the 
fungal cell wall mannose makes up about 95%, while the proteins account for only 3-5% 
of this masking layer (Chaffin et al., 1998). With less ligand to bind to, a decrease in 
protein may have a greater effect on the percentage of biotin bound to the cell wall than a 
decrease in sugar on the percentage of ConA. Another possible reason for this 
discrepancy between the ConA and biotinylation levels in cells with β-glucan exposure is 
the accessibility of the ligand to the probe. ConA is a bulky protein, whereas biotin-XX 
SSE, with two aminohexanoyl groups (xx) and sulfosuccinimidyl ester (SSE) attached, 
may reach farther into the mannoprotein layer and have better accessibility to its ligand 
(Molecular Probes). The physiological relevance of the differences in streptavidin 
labeling is supported by the co-localization of anti-β-glucan binding and loss of label. 
Further suggesting the greater relevance of examining protein loss, rather than loss of 
sugar, is our demonstration that proteinase K causes β-glucan exposure (Figure 9). As 
biotinylation labels proteins and ConA labels mannose, the use of biotin would better 
represent the cell wall damage that leads to β-glucan exposure. 
Using streptavidin to measure protein degradation also presents an issue in the use 
of biotinylation. Because the filaments were labeled with streptavidin, a protein, before 
the incubation with neutrophils, the decrease in streptavidin labeling may indicate merely 
the loss of streptavidin rather than loss of cell wall mannoprotein. This does not 
significantly diminish our findings, however, because if the neutrophils are damaging 
either just the fluorescently-labeled streptavidin or both the streptavidin and the masking 
cell wall proteins, this data still demonstrates that the neutrophils have the ability to 
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destroy proteins. Further, we have shown that proteases themselves cause β-glucan 
exposure (Figure 9) and alter mannoproteins (Figure 8). Christin et al., 1997 also used 
this technique of biotinylation to label cell wall proteins and showed that neutrophils 
damage cell wall proteins. This evidence, along with our observations of β-glucan 
exposure (Figure 6B), suggests it is likely that cell wall proteins are damaged, resulting in 
the unmasking of the underlying sugar.  
A general concern in indirect immunofluorescence assays is the potential for 
cross-reactivity between secondary antibodies. Although anti-β-D-glucan antibody does 
colocalize with anti-neutrophil elastase antibody, this colocalization is not due to cross-
reactivity of the antibodies or bleed through between fluorescent channels. The patterns 
of anti-neutrophil elastase binding and anti-β-D-glucan binding do differ in qualitative 
images, although the image in Figure 7 may not directly address this difference.  
Our observation that not all innate immune-fungal interactions result in β-glucan 
exposure has interesting implications regarding recognition and innate immune signaling, 
especially the observation of neutrophil elastase deposition in areas where β-glucan 
exposure is absent. There are two possible implications of this observation. Fadok et al., 
2001 suggests that neutrophil elastase aids in the excitation of macrophages to produce 
pro-inflammatory cytokines. This could mean that the deposition of neutrophil elastase, 
even in the absence of β-glucan exposure, may serve the purpose of increasing the pro-
inflammatory response and the recruitment of more innate immune cells to the site of 
infection. However, Gresnigt et al., 2012 suggests that in whole neutrophils, neutrophil 
elastase inhibits the production of pro-inflammatory cytokines by macrophages. This 
result could suggest that deposited neutrophil elastase is used as a modulator of the pro-
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inflammatory response, possibly to ensure that there is not an over-recruitment of innate 
immune cells that could potentially lead to damage of the surrounding tissue. Further 
work with neutrophil elastase to understand its abilities to damage the cell wall as a 
protease and its effect on recognition and excitation of macrophages is elaborated below. 
There are a few steps that would further our study of the interactions of whole 
neutrophils and the fungal cell wall. First would be to establish the importance of 
neutrophils in vivo by studying the effect of the absence of neutrophils on cell wall 
protein damage and/or β-glucan exposure in the murine kidney infection. Preliminary 
results have shown that C. albicans in the kidneys of mice that have been depleted of 
neutrophils, have less β-glucan than those mice that have not undergone neutrophil 
depletion (Hopke and Wheeler, personal communication), supporting our findings done 
in vitro.  Currently we are also looking at the effects of neutrophils on the structure of the 
fungal cell wall using transmission electron microscopy. This will allow us to better 
understand localized cell wall protein degradation mediated by neutrophils.  
Establishing that neutrophils can cause cell wall protein damage and β-glucan 
exposure not only aids in the understanding of the C. albicans cell wall and how it reacts 
to innate immune system defenses, but it could also change the way that candidiasis is 
treated in neutropenic patients. The anti-fungal caspofungin, an echinocandin, has been 
shown to artificially expose β-glucan (Wheeler et al., 2008). After further establishment 
of the importance of neutrophils in the exposure of β-glucan, caspofungin could be 
shown to be a replacement for neutrophils. Caspofungin has already been shown to be 
efficacious in treating C. albicans infections in neutropenic mice (Krishnan-Natesan et 
al., 2010). This, along with our research, emphasizes the potential importance of 
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echinocandins like caspofungin in the treatment protocols of neutropenic patients with 
candidiasis. 
 
Proteases can expose β-glucan and could be the mechanism for neutrophil-
mediated attack 
 Once we established that neutrophils could cause cell wall-associated protein 
damage and β-glucan exposure, we wanted to understand how neutrophils mediate this 
effect. Neutrophils have a variety of weapons to use against pathogens including reactive 
oxygen species (ROS), anti-microbial peptides, and proteases (Kindt et al., 2007). As the 
damage was to cell wall proteins, we hypothesized that neutrophils were using proteases 
to cause this damage and expose β-glucan. This idea was also suggested by our finding 
that neutrophil elastase, a protease, is deposited by neutrophils in areas of localized β-
glucan exposure. To study the ability of proteases to expose β-glucan we used proteinase 
K, a general protease, as a model for neutrophil-derived proteases. Proteinase K was 
chosen as a model for its properties as a strong protease, uninhibited by glycosylation or 
native structure like elastase or cathepsin G, proteases that alone have shown little to no 
affect on the fungal cell wall (Christin et al., 1997). What we found, using proteinase K, 
was that proteases can cause both cell wall protein damage and β-glucan exposure, as 
seen by transmission electron microscopy and immunofluoresence microscopy 
respectively.  
We obtained extensive qualitative data that suggests that proteinase K increases β-
glucan exposure on fungal filaments. However, while the data does show that there is 
significantly greater anti-β-D-glucan labeling in the samples treated with proteinase K, 
the samples without proteinase K also have low levels of anti-β-D-glucan exposure 
  28 
(Figure 9).  This basal exposure could be due to three possible reasons. First, it has been 
shown that at early stages of filament development, anti-β-D-glucan can recognize β-
glucan in the weakened cell wall (Lavigne et al., 2006). While the filaments I work with 
in these experiments are grown overnight in RPMI to initially promote filamentation, 
both the proteinase K-treated and untreated filaments are incubated again overnight in 
RPMI and stained and imaged the next morning. With the continuous development of 
filaments, there could be enough filaments with weakened cell walls to lead to low levels 
of β-glucan exposure seen in the untreated cells. Non-specific staining by the anti-β-D-
glucan antibody could also be a factor for the low levels of fluorescence due to anti-β-D-
glucan antibody staining, although qualitative studies done to optimize anti-β-glucan 
binding at the lowest concentration on KAH3, a strain of C. albicans with exposed β-
glucan, do not support this conclusion. The final possible reason for the close levels of β-
glucan exposure in the treated and untreated cells lies in the quantification method. Even 
in cells treated with proteinase K, there are many cells that only have basal levels of 
exposure, seen in the untreated cells, and other filaments with only small areas of intense, 
localized β-glucan exposure. As we used the CellProfiler quantification technique here to 
observe the average β-glucan exposure on a cell-by-cell basis, localized areas of intense 
fluorescence due to anti-β-glucan staining or areas of basal exposure may have been 
misrepresented. Combined with low levels of anti-β-D-glucan staining due to possible 
weakness of the growing fungal cell wall could lead to levels of anti-β-D-glucan staining 
higher than expected in fungal filaments not treated with proteinase K.  
Just like our findings with whole neutrophils, our research into the possible role of 
proteases in the exposure of β-glucan allows for interesting insights into innate immune-
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fungal interactions. We have established that proteases can damage cell wall proteins and 
expose β-glucan and that the protease neutrophil elastase is present at these sites, 
meaning that neutrophils could use proteases to damage cell wall proteins and expose β-
glucan. These results are supported by some previous studies, but not by others. While 
Reeves et al., 2002 demonstrated that elastase was necessary for mice to resist 
candidiasis, Christin et al., 1997 showed that protease inhibitors did not decrease a 
neutrophil’s ability to damage cell wall proteins and that proteases alone could not induce 
cell wall damage. Together with our research, this data indicates the potential for a 
synergistic effect of multiple mechanisms in the exposure of β-glucan. We have 
attempted to use sodium hypochlorite to investigate the independent role of ROS, but 
found that it was unable to produce β-glucan exposure unless coupled with proteinase K 
(data not shown), a result supported by research done showing that mice with chronic 
granulomatous disease do not have a decreased ability to damage fungal cell wall 
proteins (Christin et al., 1997). Still we cannot be sure that the effect we see at the C. 
albicans cell wall is due only to proteases. At the site of neutrophil attachment, many 
compounds are likely released and the likelihood that they work together to expose β-
glucan is good. 
Further research into the role of proteases in the exposure of β-glucan is necessary 
to fully understand their importance independently and synergistically. As we have seen 
that neutrophil elastase is present at sites of β-glucan exposure, it would be interesting to 
see if neutrophil elastase inhibitors affect the ability of purified neutrophils to expose β-
glucan in vitro. Using protease deficient mice, like the ones used in Reeves et al., 2002, 
would also provide greater insight into the role of proteases on β-glucan exposure. We 
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could use neutrophils from these mice in vitro to observe β-glucan exposure in 
neutrophils without these two major proteases. We could also use these specialized mice 
to observe levels of β-glucan exposure in vivo in the kidney infection, which would help 
to further test our hypothesis that proteases play an important role in mediating this 
effect.  
 
Neutrophil-damaged fungal filaments and neutrophil lysate induce TNF-α 
production more than filaments alone 
 As one of our reasons for studying β-glucan was its role as a PAMP for the innate 
immune system, we decided to investigate the ability of our neutrophil-damaged C. 
albicans filaments to induce cytokine production by macrophages. Fungal filaments with 
β-glucan exposed by caspofungin hyperelicit TNF-α (Wheeler and Fink, 2006). We 
hypothesized that both our mutant strain of C. albicans with confirmed β-glucan 
exposure and neutrophil-damaged filaments with β-glucan exposure would both 
hyperelicit TNF-α as well. What we observed, however, was that the mutant strain of C. 
albicans did not induce TNF-α production more than the wild-type (Figure 10A) and that 
both our neutrophil-damaged filaments and our undamaged fungal filaments with added 
neutrophil lysate elicited significantly greater TNF-α production than filaments alone 
(Figure 10B).  
Using an assay to attempt to model a complex in vivo interaction in vitro is 
always imperfect. Our first issue was in our control experiments. The mutant strains of C. 
albicans with exposed β-glucan did not have significantly more TNF-α production than 
our wild-type control strain. Although only two individual experiments went into this 
result, the triplicates within the experiments were consistent and the standard curves 
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behaved as expected. One possible reason for this result could be that we did not expose 
the macrophages to the fungal cells for long enough to produce enough TNF-α. We 
exposed our macrophages to C. albicans cells for 2 and 4 hours. It has been shown that 
RAW246.7 macrophages produce TNF-α when exposed to a mutant strain of                  
S. cerevisiae with exposed β-glucan for 6 hours, and even after 6 hours, the TNF-α 
production was significant but still close to the wild-type (Wheeler and Fink, 2006). This 
reason seems unlikely though as we see TNF-α production in the experiment with the 
neutrophil- damaged C. albicans. Another possible reason concerns the type of 
macrophages we used. In previous work, the macrophages used for this type of challenge 
were bone marrow-derived macrophages (Fadok et al., 2001; Wheeler and Fink, 2006). 
Wheeler and Fink, 2006 has shown that RAW246.7 macrophages had a limited response 
to positive controls, suggesting that bone marrow-derived macrophages may be the 
superior source.   
 Our second concern was the effect of neutrophil lysate on our assay using 
neutrophil-damaged C. albicans. Due to our experimental procedure, the neutrophils 
were lysed before the challenge with macrophages. Not only did damaged C. albicans 
with this neutrophil lysate elicit significantly higher amounts of TNF-α than undamaged 
filaments alone, but the undamaged filaments with the neutrophil lysate also elicited 
significantly more TNF-α than undamaged filaments alone. One possible explanation of 
these results is that the neutrophil lysate was exciting macrophages to the extent that we 
could not distinguish how the macrophages were reacting to the damaged fungal 
filaments. Previous work supports this conclusion that neutrophil lysate stimulates 
macrophages to produce TNF-α (Fadok et al., 2001). Interestingly the results of the work 
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by Fadok et al., 2001 also implicate neutrophil elastase in the excitation of macrophages. 
However, recent work done by Gresnigt et al., 2012, suggesting that neutrophil elastase 
inhibits the production of inflammatory cytokines, offers another view. Perhaps 
neutrophil elastase deposited at high concentrations on the fungal cell wall by whole 
neutrophils inhibits a pro-inflammatory response while free-floating neutrophil elastase 
excites a pro-inflammatory response. Further study is needed to better understand this 
relationship.  
 This assay may provide interesting insight to help better understand the role of β-
glucan as a PAMP in innate immune recognition, but it needs to be optimized. To 
improve this assay we could first use bone marrow-derived macrophages, which have 
been shown to recognize exposed β-glucan (Wheeler and Fink, 2006). In order to make 
sure we are just seeing TNF-α production attributable to β-glucan exposure, we may need 
to use a method of removing the neutrophils without lysis. Removal of neutrophils 
without lysis would be difficult as the neutrophils are wrapped around the fungal 
filaments of interest. Instead, we could use a protease inhibitor like AEBSF or PMSF, 
used in Fadok et al., 2001, to decrease the impact of the neutrophil lysate on TNF-α 
production. Another interesting assay would be to leave the neutrophils whole and 
observe the production of TNF-α from macrophages incubated with both neutrophils and 
damaged C. albicans to possibly better model the in vivo setting. This assay would also 
serve to confirm or refute the findings by Gresnigt et al., 2012 implicating neutrophils in 
the inhibition of a pro-inflammatory response. With optimization, this assay will help us 
to better understand the role our neutrophil-damaged filaments play in innate immune 
recognition of C. albicans. 
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Our research has allowed us to better understand the interactions between our 
innate immune system and the fungal cell wall. We have developed a mechanistic model 
in vitro to potentially explain the β-glucan exposure observed in the mouse kidney 
infection (Wheeler et al., 2008). We have shown that neutrophils can attach to and wrap 
around fungal filaments and that they deposit compounds like neutrophil elastase onto the 
fungal cell wall. We have also shown that this interactions results in localized damage to 
masking cell wall-associated proteins and subsequent β-glucan exposure. We have 
hypothesized and supported here that it could be the action of proteases causing this 
damage and exposure. Finally we have begun to investigate the role of these naturally 
damaged C. albicans filaments in recognition and signaling by the innate immune 
system. Through our work we now better understand the fungal cell wall and our innate 
defenses against C. albicans. Hopefully, through our research we can find better 
treatment methods that will help us to unmask candidiasis. 
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Figure Legends 
Figure 1: β-glucan is a masked component of the fungal cell wall. (A) An 
electronmicrograph of the cross section of the C. albicans cell wall shows a thin layer of 
mannoproteins masking a thicker layer of β-glucan. (B) The chemical structure of β-
glucan highlighting the β(1,3) linkages. 
 
Figure 2: Previous knowledge about C. albicans pathogenesis in the murine kidney 
infection. It has been shown that between days three and five of a C. albicans infection in 
the murine kidney, a shift in recognition occurs from mannan-based to mannan- and β-
glucan-based. The mechanism by which β-glucan becomes unmasked is not thoroughly 
understood. 
 
Figure 3: Quantification of immunofluorescence images using CellProfiler software. 
For quantifying immunofluorescence images, cell segments were outlined in the GFP 
channel so the selection was blind in the respect to anti-β-glucan and streptavidin. The 
CellProfiler software then calculated the mean fluorescence only along the drawn line so 
that only the mean fluorescence at the edge was considered. This measurement was 
recorded in the fluorescence channel for anti-β-glucan, and streptavidin when necessary. 
Cell segments were avoided if they overlapped other cells or if they were at the ends of 
cells to ensure that the anti-β-glucan and streptavidin levels could only be attributed to 
one cell and that a decrease in streptavidin was not due to growth post-biotinylation. 
Scale bar= 20 µm. 
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Figure 4: Quantification of immunofluorescence images using AxioVisionLE 
software. When quantifying areas of localized cell wall damage, a box of constant area 
was used in order to measure fluorescence due to immunofluorescence staining of β-
glucan exposure and cell wall proteins labeled with fluorescent streptavidin. When 
choosing regions to quantify, areas of concentrated, bright fluorescence (1) were avoided 
in case free secondary antibody had collected on filaments. Cells were also not chosen if 
they were layered with other cells (2), or if they were at the end of cells (3) to ensure the 
decrease in streptavidin was due to factors other than growth of the filaments after they 
had been labeled with biotin and fluorescent streptavidin. Examples of areas that were 
quantified are shown in red boxes. 
 
Figure 5: Purified neutrophils attach to C. albicans filaments and locally disrupt cell 
wall protein labeling in vitro. Neutrophils purified from the bone marrow of C57BL/6J 
mice were added to WT-GFP C. albicans filaments labeled with biotin followed by 
streptavidin-AlexaFluor 647. Time lapse images were taken over 44 minutes. Two sites 
of neutrophil attachment have been enclosed by white boxes. Box 1 highlights a filament 
where attachment occurs, and a decrease of streptavidin is observed throughout the rest of 
the time lapse. Box 2 highlights another area of neutrophil attachment, which does not 
exhibit a decrease of cell wall protein labeling. Scale bar= 20 µm. 
 
Figure 6: Purified neutrophils cause localized exposure of β-glucan and a 
corresponding local decrease in cell wall protein labeling. Neutrophils were purified 
from C57BL/6J mice then incubated at 37°C for 2.5 hours with WT-GFP C. albicans 
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filaments, which were biotinylated using a fluorescently labeled streptavidin. After 
incubation, the neutrophils were lysed and the C. albicans filaments were stained with an 
anti-β-D-glucan antibody followed by a fluorescently labeled secondary antibody. 
Qualitatively an increase of β-glucan was observed in filaments treated with neutrophils, 
n= 14.  (A) Mean fluorescence on a cell-by-cell basis due to fluorescent streptavidin and 
anti-β-D-glucan staining was measured using the CellProfiler quantification technique. 
The graph represents one individual experiment, n= 3. *p< 0.001(B) Localized, mean 
fluorescence due to anti-β-D-glucan staining and fluorescent streptavidin labeling was 
measured using AxioVisionLE quantification technique. Quantified areas with visible β-
glucan exposure are indicated as “Exposed”. Quantified areas without visible β-glucan 
exposure are indicated as “Control”. The graph represents one experiment, n= 3, scale 
bar= 20 µm. 
 
Figure 7: Areas of β-glucan exposure exhibit deposition of neutrophil elastase.  
(A) Neutrophils were purified from C57BL/6J mice then incubated at 37°C for 2.5 hours 
with WT-GFP C. albicans filaments. After incubation the neutrophils were lysed. (B) 
Lysed neutrophils were added to C. albicans filaments after both had been incubated 
separately at 37°C for 2.5 hours. (C) C. albicans filaments were incubated at 37°C for 2.5 
hours and did not receive lysed neutrophils. All samples were then stained with anti-β-D-
glucan and anti-neutrophil elastase antibodies followed by staining with fluorescently 
labeled secondary antibodies. n= 5, scale bar= 10 µm. 
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Figure 8: Treatment with proteinase K alters the structure of the C. albicans cell 
wall. C. albicans filaments were treated with or without 0.74 mg/mL of proteinase K in 
RPMI at 37°C overnight. After incubation the proteinase K was washed from the cells 
and the filaments were fixed in 2% formaldehyde, 2% gluteraldehyde, 1 mM CaCl2, 1 
mM sorbitol and 40 mM potassium phosphate buffer. (A) Images at high magnification, 
scale bar= 100 nm. (B) Images at medium magnification, scale bar= 200 nm. (C) Images 
at low magnification, scale bar= 2 µm. 
 
Figure 9: Proteinase K induces the exposure of β-glucan. (A-B) WT-GFP C. albicans 
filaments were treated with or without 0.74 mg/mL of proteinase K overnight at 37°C in 
RPMI to allow filamentation. The proteinase K was then washed from the cells and 
filaments were stained with an anti-β-glucan antibody followed by a Cy3-conjugated 
secondary antibody. (A) Representative images of qualitative data, n= 10. (B) For 
quantification, the mean fluorescence on individual cell segments due to anti-β-D-glucan 
staining was measured using CellProfiler software. The graph represents the average and 
standard error of fluorescence due to anti-β-D-glucan staining and n= 3. *p= 0.01 by 
student’s t-test. 
 
Figure 10: Neutrophil-damaged C. albicans filaments and lysed neutrophils induce 
macrophages to produce more TNF-α than C. albicans filaments alone.  
(A-B) C. albicans cells were incubated with RAW264.7 macrophages for 2 hours at 37°C 
with 5% CO2. After incubation, the supernatant was removed and a sandwich ELISA for 
TNF-α was performed in triplicate with known amounts of TNF-α as standards. (A) Two 
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strains of UV inactivated C. albicans (KAH3 and WT-GFP) yeast cells were incubated 
with macrophages, one representative graph was used, and n= 2. (B) C. albicans (WT-
GFP) filaments were incubated with primary murine neutrophils, then the neutrophils 
were lysed, or lysed neutrophils were added to filaments post-incubation, or filaments 
were incubated alone and did not have neutrophil lysate added. This graph represents one 
representative experiment, and n= 2. *p< 0.005 by student’s t-test. 
 
Figure 11: Proposed mechanistic model for β-glucan exposure observed in vivo. 
Between day 3 and day 5 of a C. albicans infection in the mouse kidney, neutrophils, 
wrap around C. albicans filaments, and release proteases, which then expose β-glucan by 
damaging the outer, masking layer of mannoproteins. This exposure causes a shift from 
mannan-based to mannan- and β-glucan-based recognition. With perfection of this assay, 
further investigation into the role of β-glucan exposure on innate immune cell recognition 
can be performed. 
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Appendices 
Appendix I: Streptavidin Fluorophors Used 
 
Streptavidin Manufacturer (Cat. Number) 
Streptavidin-AlexaFluor 647 Jackson Immunoresearch (016-600-084) 
DTAF-Streptavidin Jackson Immunoresearch (016-010-084 
 
Appendix II: Primary and Secondary Antibodies Used: 
 
Primary Antibodies Manufacturer (Cat. 
Number) 
Concentration Used 
anti-β-D-glucan mouse 
monoclonal IgG 
 Biosupplies Australia 
(400-2) 
1:800 
anti- neutrophil elastase 
goat polyclonal IgG 
Santa Cruz Biotechnology, 
Inc (sc-9521) 
1:50 
 
Secondary Antibody Used with anti-β-glucan Antibody Only 
Secondary Antibody Manufacturer (Cat. 
Number) 
Concentration Used 
Cy3 goat anti-mouse 
IgG 
Jackson Immunoresearch 1:100-1:400 
 
Secondary Antibody Used with anti-β-glucan and anti-Neutrophil Elastase 
Antibodies 
Secondary Antibody Manufacturer (Cat. 
Number) 
Concentration Used 
549 donkey anti-mouse 
IgG 
Jackson Immunoresearch 1:200 
Cy5 donkey anti-goat 
IgG 
Jackson Immunoresearch 1:200 
 
Appendix III: Proteinase K Treatment Reagents: 
 
 Proteinase K + Proteinase K - 
C. albicans 3x108 cells/mL 100 µL 100 µL 
RPMI-1640 100 µL 100 µL 
2M Sorbitol 100 µL 100 µL 
1xPBS pH 7.2 25 µL 37.5 µL 
1M CaCl2 1 µL 1 µL 
Proteinase K, 20 mg/mL 12.5 µL - 
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